Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical) End User (Clinical Labs, Hospitals) - Global Forecast to 2025

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.3             MARKET SCOPE
1.3.1              MARKETS COVERED.. 18
1.3.2              YEARS CONSIDERED FOR THE STUDY
1.4             CURRENCY
1.5             LIMITATIONS
1.6             STAKEHOLDERS
1.7             SUMMARY OF CHANGES MADE

2.... RESEARCH METHODOLOGY

2.1             RESEARCH APPROACH
2.1.1              SECONDARY DATA
2.1.1.1            KEY DATA FROM SECONDARY SOURCES
2.1.2              PRIMARY DATA
2.1.2.1            BREAKDOWN OF PRIMARIES
2.2             MARKET SIZE ESTIMATION
2.2.1              BOTTOM-UP APPROACH
2.2.2              TOP-DOWN APPROACH.. 25
2.3             MARKET BREAKDOWN AND DATA TRIANGULATION
2.4             ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1             COAGULATION ANALYZERS MARKET OVERVIEW... 32
4.2             NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY PRODUCT & COUNTRY (2020)
4.3             COAGULATION ANALYZERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
5.2.1              DRIVERS
5.2.1.1            INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES AND
BLOOD DISORDERS
5.2.1.2            RISING GERIATRIC POPULATION
5.2.1.3            TECHNOLOGICAL ADVANCEMENTS
5.2.2              RESTRAINTS
5.2.2.1            HIGH COST OF FULLY AUTOMATED COAGULATION ANALYZERS
5.2.3              OPPORTUNITIES
5.2.3.1            EMERGING MARKETS
5.2.3.2            GROWING REAGENT RENTAL BUSINESS
5.2.4              CHALLENGES
5.2.4.1            STRINGENT AND TIME-CONSUMING REGULATORY PROCESSES SIGNIFICANTLY INCREASING THE GESTATION PERIOD FOR PRODUCT LAUNCHES

6.... COAGULATION ANALYZERS MARKET, BY PRODUCT

6.1             INTRODUCTION
6.2             CLINICAL LABORATORY ANALYZERS
6.2.1              CONSUMABLES
6.2.1.1            REAGENTS
6.2.1.1.1            REAGENTS ACCOUNTED FOR THE LARGEST SHARE OF
THE CONSUMABLES MARKET IN 2019
6.2.1.2            STANDARDS, CONTROLS, AND CALIBRATIONS
6.2.1.2.1            STANDARDS, CONTROLS, AND CALIBRATIONS PLAY AN IMPORTANT ROLE IN ENSURING THE PERFORMANCE AND ACCURACY OF INSTRUMENTS
6.2.2              SYSTEMS
6.2.2.1            AUTOMATED SYSTEMS
6.2.2.1.1            FULLY AUTOMATED SYSTEMS DELIVER RESULTS WITH HIGH ACCURACY AND PRECISION IN SHORTER PERIODS
6.2.2.2            SEMI-AUTOMATED SYSTEMS
6.2.2.2.1            COST-EFFECTIVENESS OF SEMI-AUTOMATED SYSTEMS TO DRIVE THEIR ADOPTION
6.2.2.3            MANUAL SYSTEMS
6.2.2.3.1            MANUAL SYSTEMS TO WITNESS LOWER GROWTH DURING
THE FORECAST PERIOD
6.3             POINT-OF-CARE TESTING ANALYZERS
6.3.1              POC TESTING ANALYZERS TO WITNESS HIGH DEMAND GROWTH IN
THE COMING YEARS

7.... COAGULATION ANALYZERS MARKET, BY TEST. 50

7.1             INTRODUCTION
7.2             PROTHROMBIN TIME TESTING
7.2.1              PT/INR TESTS DOMINATED THE MARKET IN 2019
7.3             D-DIMER TESTING
7.3.1              D-DIMER TESTS ARE USED TO CHECK BLOOD CLOTTING ISSUES
7.4             FIBRINOGEN TESTING
7.4.1              GROWING PREVALENCE OF CARDIOVASCULAR DISEASES TO INCREASE
THE DEMAND FOR FIBRINOGEN TESTS
7.5             ACTIVATED CLOTTING TIME TESTING
7.5.1              ACT TESTS HELP HEALTHCARE PROVIDERS TO FIND THE RIGHT DOSAGE
OF HEPARIN
7.6             ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTING
7.6.1              GROWING NUMBER OF ANGIOPLASTY AND DIALYSIS PROCEDURES TO SUPPORT MARKET GROWTH
7.7             PLATELET FUNCTION TESTS
7.7.1              PLATELET FUNCTION TESTS ARE PERFORMED TO EVALUATE THE ABILITY OF PLATELETS TO CLUMP TOGETHER
7.8             ANTI-FACTOR XA TESTS
7.8.1              ANTI-FACTOR XA TESTS AID IN THE MONITORING OF STANDARD HEPARIN THERAPY FOR UFH
7.9             HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT
7.9.1              DUE TO LIMITED APPLICATIONS, THIS TEST SEGMENT HAS A VERY SMALL SHARE IN THE COAGULATION ANALYZERS MARKET
7.10          OTHER COAGULATION TESTS

8.... COAGULATION ANALYZERS MARKET, BY TECHNOLOGY

8.1             INTRODUCTION
8.2             OPTICAL TECHNOLOGY
8.2.1              OPTICAL TECHNOLOGY SEGMENT DOMINATED THE MARKET IN 2019
8.3             MECHANICAL TECHNOLOGY
8.3.1              MECHANICAL ANALYZERS ARE NOT AFFECTED BY ICTERIC OR
LIPEMIC PLASMA
8.4             ELECTROCHEMICAL TECHNOLOGY
8.4.1              INCREASING DEMAND FOR SELF-TESTING TO DRIVE MARKET GROWTH
8.5             OTHER TECHNOLOGIES

9.... COAGULATION ANALYZERS MARKET, BY END USER

9.1             INTRODUCTION
9.2             HOSPITALS
9.2.1              HIGH PREVALENCE OF BLOOD-RELATED DISORDERS WILL RESULT IN HIGH MARKET GROWTH
9.3             CLINICAL LABORATORIES
9.3.1              CLINICAL LABORATORIES FORMED THE LARGEST END-USER SEGMENT IN THIS MARKET
9.4             OTHER END USERS

10.. COAGULATION ANALYZERS MARKET, BY REGION

10.1          INTRODUCTION
10.2          NORTH AMERICA
10.2.1            US
10.2.1.1          FAVORABLE RESEARCH SCENARIO WILL DRIVE MARKET GROWTH IN THE US
10.2.2            CANADA
10.2.2.1          RISING DEMAND FOR BLOOD AND BLOOD COMPONENTS TO SUPPORT
MARKET GROWTH

10.3          EUROPE
10.3.1            GERMANY
10.3.1.1          INCREASING INCIDENCE OF HIV IS A MAJOR FACTOR DRIVING THE GROWTH OF
THE COAGULATION ANALYZERS MARKET IN GERMANY
10.3.2            UK
10.3.2.1          GOVERNMENT SUPPORT TO DEVELOP INNOVATIVE DIAGNOSTIC KITS WILL BOOST MARKET GROWTH IN THE UK
10.3.3            FRANCE
10.3.3.1          PRESENCE OF PROPER PROTOCOLS AND GUIDELINES FOR DIAGNOSTICS TO PROPEL MARKET GROWTH IN FRANCE
10.3.4            ITALY
10.3.4.1          INCREASING PREFERENCE FOR COAGULATION TESTING DURING TRANSPLANTATION WILL RESULT IN MARKET GROWTH
10.3.5            SPAIN
10.3.5.1          CONSOLIDATION OF LABORATORIES IN SPAIN WILL DRIVE MARKET GROWTH
10.3.6            REST OF EUROPE
10.4          ASIA PACIFIC
10.4.1            CHINA
10.4.1.1          GOVERNMENT INITIATIVES AND IMPROVING HEALTHCARE INFRASTRUCTURE TO AID MARKET GROWTH
10.4.2            JAPAN
10.4.2.1          RISING POC TESTING WILL CONTRIBUTE TO MARKET GROWTH IN JAPAN
10.4.3            INDIA
10.4.3.1          HIGH BURDEN OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
10.4.4            REST OF ASIA PACIFIC
10.5          LATIN AMERICA
10.5.1            DEARTH OF QUALIFIED HEALTHCARE PROFESSIONALS TO RESTRAIN MARKET GROWTH IN LATAM
10.6          MIDDLE EAST & AFRICA
10.6.1            HIGH PREVALENCE OF BLOOD DISORDERS TO SUPPORT MARKET GROWTH IN THE MEA

11.. COMPETITIVE LANDSCAPE

11.1          OVERVIEW
11.2          MARKET RANKING ANALYSIS
11.3          COMPETITIVE LEADERSHIP MAPPING
11.3.1            VISIONARY LEADERS
11.3.2            INNOVATORS
11.3.3            DYNAMIC DIFFERENTIATORS
11.3.4            EMERGING COMPANIES
11.4          COMPETITIVE SITUATION AND TRENDS
11.4.1            PRODUCT LAUNCHES AND ENHANCEMENTS
11.4.2            PARTNERSHIPS AND AGREEMENTS
11.4.3            MERGERS & ACQUISITIONS

12.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, COVID-19 IMPACT, MNM VIEW)*
12.1          ABBOTT LABORATORIES
12.2          THERMO FISHER SCIENTIFIC, INC.
12.3          NIHON KOHDEN CORPORATION
12.4          ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
12.5          SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG)
12.6          SYSMEX CORPORATION
12.7          DANAHER CORPORATION
12.8          HORIBA
12.9          DIAGNOSTICA STAGO SAS
12.10        HELENA LABORATORIES CORPORATION
12.11        MACCURA BIOTECHNOLOGY CO., LTD.
12.12        BEIJING SUCCEEDER TECHNOLOGY INC.
12.13        HYCEL HANDELSGES.M.B.H.
12.14        GENRUI BIOTECH INC.
12.15        ERBA DIAGNOSTICS MANNHEIM GMBH (A TRANSASIA BIO-MEDICALS LTD. COMPANY)
12.16        BIO-GROUP MEDICAL SYSTEM
12.17        ROBIMES INDIA PVT. LTD.
12.18        MERIL LIFE SCIENCES PVT. LTD.
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, COVID-19 IMPACT, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13.. APPENDIX

LIST OF TABLES

TABLE 1              NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2019 AND 2050
TABLE 2              COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 3              CLINICAL LABORATORY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION)
TABLE 4              CLINICAL LABORATORY ANALYZERS MARKET, BY REGION,
2018–2025 (USD MILLION)
TABLE 5              CLINICAL LABORATORY COAGULATION ANALYZER CONSUMABLES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
TABLE 6              CLINICAL LABORATORY COAGULATION ANALYZER CONSUMABLES MARKET,
BY REGION, 2018–2025 (USD MILLION)
TABLE 7              REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8              STANDARDS, CONTROLS, AND CALIBRATIONS MARKET, BY REGION,
2018–2025 (USD MILLION)
TABLE 9              CLINICAL LABORATORY COAGULATION ANALYZER SYSTEMS MARKET,
BY TYPE, 2018–2025 (USD MILLION)
TABLE 10            CLINICAL LABORATORY COAGULATION ANALYZER SYSTEMS MARKET,
BY REGION, 2018–2025 (USD MILLION)
TABLE 11            AUTOMATED SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 12            SEMI-AUTOMATED SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13            MANUAL SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 14            POC TESTING ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15            COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 16            PROTHROMBIN TIME TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 17            D-DIMER TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18            FIBRINOGEN TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 19            ACT TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 20            APTT TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21            PLATELET FUNCTION TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 22            ANTI-FACTOR XA TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 23            HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 24            OTHER COAGULATION TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 25            COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 26            OPTICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 27            MECHANICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 28            ELECTROCHEMICAL TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION)
TABLE 29            OTHER TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 30            COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 31            HOSPITALS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 32            CLINICAL LABORATORIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 33            OTHER END USERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 34            COAGULATION ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 35            NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 36            NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 37            NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 38            NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION)
TABLE 39            NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 40            US: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 41            US: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 42            US: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 43            US: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 44            CANADA: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 45            CANADA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 46            CANADA: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION)
TABLE 47            CANADA: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 48            EUROPE: COAGULATION ANALYZERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 49            EUROPE: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 50            EUROPE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 51            EUROPE: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION)
TABLE 52            EUROPE: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 53            GERMANY: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 54            GERMANY: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 55            GERMANY: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION)
TABLE 56            GERMANY: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 57            UK: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 58            UK: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 59            UK: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 60            UK: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 61            FRANCE: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 62            FRANCE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 63            FRANCE: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION)
TABLE 64            FRANCE: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 65            ITALY: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 66            ITALY: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 67            ITALY: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 68            ITALY: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 69            SPAIN: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 70            SPAIN: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 71            SPAIN: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 72            SPAIN: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 73            ROE: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 74            ROE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 75            ROE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 76            ROE: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 77            APAC: COAGULATION ANALYZERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
TABLE 78            APAC: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 79            APAC: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 80            ASIA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 81            APAC: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 82            CHINA: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 83            CHINA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 84            CHINA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 85            CHINA: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 86            JAPAN: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 87            JAPAN: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 88            JAPAN: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 89            JAPAN: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 90            INDIA: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 91            INDIA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 92            INDIA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 93            INDIA: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 94            ROAPAC: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 95            ROAPAC: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 96            ROAPAC: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION)
TABLE 97            ROAPAC: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 98            LATAM: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 99            LATAM: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION)
TABLE 100          LATAM: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 101          LATAM: COAGULATION ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION)
TABLE 102          MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
TABLE 103          MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 104          MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY TEST,
2018–2025 (USD MILLION)
TABLE 105          MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)

LIST OF FIGURES

FIGURE 1            COAGULATION ANALYZERS MARKET SEGMENTATION
FIGURE 2            RESEARCH DESIGN
FIGURE 3            BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION
FIGURE 4            COAGULATION ANALYZERS MARKET: TOP-DOWN APPROACH
FIGURE 5            DATA TRIANGULATION METHODOLOGY
FIGURE 6            COAGULATION ANALYZERS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 7            COAGULATION ANALYZERS MARKET, BY TEST, 2020 VS. 2025 (USD MILLION)
FIGURE 8            COAGULATION ANALYZERS MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION)
FIGURE 9            COAGULATION ANALYZERS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10          COAGULATION ANALYZERS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
FIGURE 11          INCREASING PREVALENCE OF BLOOD DISORDERS TO DRIVE MARKET GROWTH
FIGURE 12          CLINICAL LABORATORY ANALYZERS SEGMENT IS EXPECTED TO ACCOUNT FOR
THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020   32
FIGURE 13          ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
FIGURE 14          COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES
FIGURE 15          NORTH AMERICA: COAGULATION ANALYZERS MARKET SNAPSHOT
FIGURE 16          PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM JANUARY 2017 TO MARCH 2020
FIGURE 17          COAGULATION ANALYZERS MARKET RANKING ANALYSIS, BY PLAYER, 2019
FIGURE 18          COAGULATION ANALYZERS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 19          ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 20          THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 21          NIHON KOHDEN: COMPANY SNAPSHOT (2019)
FIGURE 22          ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)
FIGURE 23          SIEMENS HEALTHINEERS GROUP: COMPANY SNAPSHOT (2019)
FIGURE 24          SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)

当レポートのプレスリリースは発行されておりません。